Dirk Schadendorf (D Schadendorf)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 102

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Journal for immunotherapy of cancer

Journal of the European Academy of Dermatology and Venereology : JEADV

Journal of medical Internet research

This page only lists publications with an associated author ORCID identifier.

Publications

Dirk Schadendorf, Jason John Luke, Paolo Antonio Ascierto, Georgina V Long, Piotr Lukasz Rutkowski, Adnan Khattak, Michele Del Vecchio, Luis de la Cruz Merino, Jacek Mackiewicz, Vanna Chiarion Sileni, John M Kirkwood, Caroline Robert, Jean-Jacques Grob, Reinhard Dummer, Matteo S Carlino, Yujie Zhao, Mizuho Kalabis, Clemens Krepler, Alexander Eggermont, Richard A Scolyer
Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma: Outcomes in histopathologic subgroups from the randomized, double-blind, phase 3 KEYNOTE-716 trial. Journal for immunotherapy of cancer 12 (3) (2024)
Georgina V Long, Axel Hauschild, Mario Santinami, John M Kirkwood, Victoria Atkinson, Mario Mandala, Barbara Merelli, Vanna Chiarion Sileni, Marta Nyakas, Andrew Haydon, Caroline Dutriaux, Caroline Robert, Laurent Mortier, Jacob Schachter, Dirk Schadendorf, Thierry Lesimple, Ruth Plummer, James Larkin, Monique Tan, Sachin Bajirao Adnaik, Paul Burgess, Tarveen Jandoo, Reinhard Dummer
Final Results for Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma. The New England journal of medicine (2024)
Jason John Luke, Paolo Antonio Ascierto, Muhammad A Khattak, Luis de la Cruz Merino, Michele Del Vecchio, Piotr Lukasz Rutkowski, Francesco Spagnolo, Jacek Mackiewicz, Vanna Chiarion Sileni, Joanne M Jeter, Caroline Robert, Jean-Jacques Grob, Federica de Galitiis, Dirk Schadendorf, Matteo S Carlino, Xi Lawrence Wu, Mizuho Kalabis, Clemens Krepler, Alexander M M Eggermont, Georgina V Long
Pembrolizumab Versus Placebo as Adjuvant Therapy in Resected Stage IIB or IIC Melanoma: Final Analysis of Distant Metastasis-Free Survival in the Phase III KEYNOTE-716 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (14) (2024)
Jedd D Wolchok, Vanna Chiarion-Sileni, Piotr Rutkowski, C Lance Cowey, Dirk Schadendorf, John Wagstaff, Paola Queirolo, Reinhard Dummer, Marcus O Butler, Andrew G Hill, Michael A Postow, Caroline Gaudy-Marqueste, Theresa Medina, Christopher D Lao, John Walker, Iván Márquez-Rodas, John B A G Haanen, Massimo Guidoboni, Michele Maio, Patrick Schöffski, Matteo S Carlino, Shahneen Sandhu, Céleste Lebbé, Paolo Antonio Ascierto, Georgina V Long, Corey Ritchings, Ayman Nassar, Margarita Askelson, Melanie Pe Benito, Wenjia Wang, F Stephen Hodi, James Larkin, null null
Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma. The New England journal of medicine (2024)
Jason John Luke, Paolo Antonio Ascierto, Muhammad A Khattak, Luis de la Cruz Merino, Michele Del Vecchio, Piotr Lukasz Rutkowski, Francesco Spagnolo, Jacek Mackiewicz, Vanna Chiarion Sileni, Joanne M Jeter, Caroline Robert, Jean-Jacques Grob, Federica de Galitiis, Dirk Schadendorf, Matteo S Carlino, Xi Lawrence Wu, Mizuho Kalabis, Clemens Krepler, Alexander M M Eggermont, Georgina V Long
Pembrolizumab Versus Placebo as Adjuvant Therapy in Resected Stage IIB or IIC Melanoma: Final Analysis of Distant Metastasis-Free Survival in the Phase III KEYNOTE-716 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (14) (2024)
Lukas Heinlein, Roman C Maron, Achim Hekler, Sarah Haggenmüller, Christoph Wies, Jochen Sven Utikal, Friedegund Meier, Sarah Hobelsberger, Frank F Gellrich, Mildred Sergon, Axel Hauschild, Lars Einar French, Lucie Heinzerling, Justin G Schlager, Kamran Ghoreschi, Max Schlaak, Franz J Hilke, Gabriela Poch, Sören Korsing, Carola Berking, Markus Vincent Heppt, Michael Erdmann, Sebastian Haferkamp, Konstantin Drexler, Dirk Schadendorf, Wiebke Sondermann, Matthias Goebeler, Bastian Schilling, Eva Krieghoff-Henning, Titus Josef Brinker
Prospective multicenter study using artificial intelligence to improve dermoscopic melanoma diagnosis in patient care. Communications medicine 4 (1) (2024)
Nikhil I Khushalani, Patrick A Ott, Matthew J Ferris, Tina Cascone, Dirk Schadendorf, Dung T Le, Manish R Sharma, Fabrice Barlesi, William Sharfman, Jason John Luke, Ignacio Melero Bermejo, Deanne Lathers, Jaclyn Neely, Satyendra Suryawanshi, Abanti Sanyal, James L Holloway, Rasika Suryawanshi, Scott Ely, Neil H Segal
Final results of urelumab, an anti-CD137 agonist monoclonal antibody, in combination with cetuximab or nivolumab in patients with advanced solid tumors. Journal for immunotherapy of cancer 12 (3) (2024)
Danny Rischin, Brett G M Hughes, Nicole Basset-Séguin, Dirk Schadendorf, Samantha Bowyer, Sabiha Trabelsi Messai, Friedegund Meier, Thomas Kurt Eigentler, Victoria Casado Echarren, Brian Stein, Marie Beylot-Barry, Sophie Dalac, Brigitte Dréno, Michael R Migden, Axel Hausschild, Chrysalyne D Schmults, Annette M Lim, Suk-Young Yoo, Anne J Paccaly, Apostolos Papachristos, Jenny-Hoa Nguyen, Emmanuel Okoye, Frank Seebach, Jocelyn Booth, Israel Lowy, Matthew G Fury, Alexander D Guminski
High response rate with extended dosing of cemiplimab in advanced cutaneous squamous cell carcinoma. Journal for immunotherapy of cancer 12 (3) (2024)
Danny Rischin, Brett G M Hughes, Nicole Basset-Séguin, Dirk Schadendorf, Samantha Bowyer, Sabiha Trabelsi Messai, Friedegund Meier, Thomas Kurt Eigentler, Victoria Casado Echarren, Brian Stein, Marie Beylot-Barry, Sophie Dalac, Brigitte Dréno, Michael R Migden, Axel Hausschild, Chrysalyne D Schmults, Annette M Lim, Suk-Young Yoo, Anne J Paccaly, Apostolos Papachristos, Jenny-Hoa Nguyen, Emmanuel Okoye, Frank Seebach, Jocelyn Booth, Israel Lowy, Matthew G Fury, Alexander D Guminski
High response rate with extended dosing of cemiplimab in advanced cutaneous squamous cell carcinoma. Journal for immunotherapy of cancer 12 (3) (2024)
Danny Rischin, Brett G M Hughes, Nicole Basset-Séguin, Dirk Schadendorf, Samantha Bowyer, Sabiha Trabelsi Messai, Friedegund Meier, Thomas Kurt Eigentler, Victoria Casado Echarren, Brian Stein, Marie Beylot-Barry, Sophie Dalac, Brigitte Dréno, Michael R Migden, Axel Hauschild, Chrysalyne D Schmults, Annette M Lim, Suk-Young Yoo, Anne J Paccaly, Apostolos Papachristos, Jenny-Hoa Nguyen, Emmanuel Okoye, Frank Seebach, Jocelyn Booth, Israel Lowy, Matthew G Fury, Alexander D Guminski
High response rate with extended dosing of cemiplimab in advanced cutaneous squamous cell carcinoma. Journal for immunotherapy of cancer 12 (3) (2024)
Georgina V Long, Evan J Lipson, F Stephen Hodi, Paolo Antonio Ascierto, James M G Larkin, Christopher Lao, Jean-Jacques Grob, Flavia Ejzykowicz, Andriy Moshyk, Viviana Garcia-Horton, Zheng-Yi Zhou, Yiqiao Xin, Jennell Palaia, Laura McDonald, Sarah Keidel, Anthony Salvatore, Divya Patel, Leon A Sakkal, Hussein A Tawbi, Dirk Schadendorf
First-Line Nivolumab Plus Relatlimab Versus Nivolumab Plus Ipilimumab in Advanced Melanoma: An Indirect Treatment Comparison Using RELATIVITY-047 and CheckMate 067 Trial Data. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Dirk Schadendorf, Jason John Luke, Paolo Antonio Ascierto, Georgina V Long, Piotr Lukasz Rutkowski, Adnan Khattak, Michele Del Vecchio, Luis de la Cruz Merino, Jacek Mackiewicz, Vanna Chiarion Sileni, John M Kirkwood, Caroline Robert, Jean-Jacques Grob, Reinhard Dummer, Matteo S Carlino, Yujie Zhao, Mizuho Kalabis, Clemens Krepler, Alexander Eggermont, Richard A Scolyer
Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma: Outcomes in histopathologic subgroups from the randomized, double-blind, phase 3 KEYNOTE-716 trial. Journal for immunotherapy of cancer 12 (3) (2024)
Danny Rischin, Brett G M Hughes, Nicole Basset-Séguin, Dirk Schadendorf, Samantha Bowyer, Sabiha Trabelsi Messai, Friedegund Meier, Thomas Kurt Eigentler, Victoria Casado Echarren, Brian Stein, Marie Beylot-Barry, Sophie Dalac, Brigitte Dréno, Michael R Migden, Axel Hauschild, Chrysalyne D Schmults, Annette M Lim, Suk-Young Yoo, Anne J Paccaly, Apostolos Papachristos, Jenny-Hoa Nguyen, Emmanuel Okoye, Frank Seebach, Jocelyn Booth, Israel Lowy, Matthew G Fury, Alexander D Guminski
High response rate with extended dosing of cemiplimab in advanced cutaneous squamous cell carcinoma. Journal for immunotherapy of cancer 12 (3) (2024)
Jason John Luke, Paolo Antonio Ascierto, Muhammad A Khattak, Luis de la Cruz Merino, Michele Del Vecchio, Piotr Lukasz Rutkowski, Francesco Spagnolo, Jacek Mackiewicz, Vanna Chiarion Sileni, Joanne M Jeter, Caroline Robert, Jean-Jacques Grob, Federica de Galitiis, Dirk Schadendorf, Matteo S Carlino, Xi Lawrence Wu, Mizuho Kalabis, Clemens Krepler, Alexander M M Eggermont, Georgina V Long
Pembrolizumab Versus Placebo as Adjuvant Therapy in Resected Stage IIB or IIC Melanoma: Final Analysis of Distant Metastasis-Free Survival in the Phase III KEYNOTE-716 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (14) (2024)
Dirk Schadendorf, Jason John Luke, Paolo Antonio Ascierto, Georgina V Long, Piotr Lukasz Rutkowski, Adnan Khattak, Michele Del Vecchio, Luis de la Cruz Merino, Jacek Mackiewicz, Vanna Chiarion Sileni, John M Kirkwood, Caroline Robert, Jean-Jacques Grob, Reinhard Dummer, Matteo S Carlino, Yujie Zhao, Mizuho Kalabis, Clemens Krepler, Alexander Eggermont, Richard A Scolyer
Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma: Outcomes in histopathologic subgroups from the randomized, double-blind, phase 3 KEYNOTE-716 trial. Journal for immunotherapy of cancer 12 (3) (2024)
Danny Rischin, Brett G M Hughes, Nicole Basset-Séguin, Dirk Schadendorf, Samantha Bowyer, Sabiha Trabelsi Messai, Friedegund Meier, Thomas Kurt Eigentler, Victoria Casado Echarren, Brian Stein, Marie Beylot-Barry, Sophie Dalac, Brigitte Dréno, Michael R Migden, Axel Hauschild, Chrysalyne D Schmults, Annette M Lim, Suk-Young Yoo, Anne J Paccaly, Apostolos Papachristos, Jenny-Hoa Nguyen, Emmanuel Okoye, Frank Seebach, Jocelyn Booth, Israel Lowy, Matthew G Fury, Alexander D Guminski
High response rate with extended dosing of cemiplimab in advanced cutaneous squamous cell carcinoma. Journal for immunotherapy of cancer 12 (3) (2024)
Danny Rischin, Brett G M Hughes, Nicole Basset-Séguin, Dirk Schadendorf, Samantha Bowyer, Sabiha Trabelsi Messai, Friedegund Meier, Thomas Kurt Eigentler, Victoria Casado Echarren, Brian Stein, Marie Beylot-Barry, Sophie Dalac, Brigitte Dréno, Michael R Migden, Axel Hausschild, Chrysalyne D Schmults, Annette M Lim, Suk-Young Yoo, Anne J Paccaly, Apostolos Papachristos, Jenny-Hoa Nguyen, Emmanuel Okoye, Frank Seebach, Jocelyn Booth, Israel Lowy, Matthew G Fury, Alexander D Guminski
High response rate with extended dosing of cemiplimab in advanced cutaneous squamous cell carcinoma. Journal for immunotherapy of cancer 12 (3) (2024)
Nikhil I Khushalani, Patrick A Ott, Matthew J Ferris, Tina Cascone, Dirk Schadendorf, Dung T Le, Manish R Sharma, Fabrice Barlesi, William Sharfman, Jason John Luke, Ignacio Melero Bermejo, Deanne Lathers, Jaclyn Neely, Satyendra Suryawanshi, Abanti Sanyal, James L Holloway, Rasika Suryawanshi, Scott Ely, Neil H Segal
Final results of urelumab, an anti-CD137 agonist monoclonal antibody, in combination with cetuximab or nivolumab in patients with advanced solid tumors. Journal for immunotherapy of cancer 12 (3) (2024)
Dirk Schadendorf, Jason John Luke, Paolo Antonio Ascierto, Georgina V Long, Piotr Lukasz Rutkowski, Adnan Khattak, Michele Del Vecchio, Luis de la Cruz Merino, Jacek Mackiewicz, Vanna Chiarion Sileni, John M Kirkwood, Caroline Robert, Jean-Jacques Grob, Reinhard Dummer, Matteo S Carlino, Yujie Zhao, Mizuho Kalabis, Clemens Krepler, Alexander Eggermont, Richard A Scolyer
Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma: Outcomes in histopathologic subgroups from the randomized, double-blind, phase 3 KEYNOTE-716 trial. Journal for immunotherapy of cancer 12 (3) (2024)
Jason John Luke, Paolo Antonio Ascierto, Muhammad A Khattak, Luis de la Cruz Merino, Michele Del Vecchio, Piotr Lukasz Rutkowski, Francesco Spagnolo, Jacek Mackiewicz, Vanna Chiarion Sileni, Joanne M Jeter, Caroline Robert, Jean-Jacques Grob, Federica de Galitiis, Dirk Schadendorf, Matteo S Carlino, Xi Lawrence Wu, Mizuho Kalabis, Clemens Krepler, Alexander M M Eggermont, Georgina V Long
Pembrolizumab Versus Placebo as Adjuvant Therapy in Resected Stage IIB or IIC Melanoma: Final Analysis of Distant Metastasis-Free Survival in the Phase III KEYNOTE-716 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Nikhil I Khushalani, Patrick A Ott, Matthew J Ferris, Tina Cascone, Dirk Schadendorf, Dung T Le, Manish R Sharma, Fabrice Barlesi, William Sharfman, Jason John Luke, Ignacio Melero Bermejo, Deanne Lathers, Jaclyn Neely, Satyendra Suryawanshi, Abanti Sanyal, James L Holloway, Rasika Suryawanshi, Scott Ely, Neil H Segal
Final results of urelumab, an anti-CD137 agonist monoclonal antibody, in combination with cetuximab or nivolumab in patients with advanced solid tumors. Journal for immunotherapy of cancer 12 (3) (2024)
Nikhil I Khushalani, Patrick A Ott, Matthew J Ferris, Tina Cascone, Dirk Schadendorf, Dung T Le, Manish R Sharma, Fabrice Barlesi, William Sharfman, Jason John Luke, Ignacio Melero Bermejo, Deanne Lathers, Jaclyn Neely, Satyendra Suryawanshi, Abanti Sanyal, James L Holloway, Rasika Suryawanshi, Scott Ely, Neil H Segal
Final results of urelumab, an anti-CD137 agonist monoclonal antibody, in combination with cetuximab or nivolumab in patients with advanced solid tumors. Journal for immunotherapy of cancer 12 (3) (2024)
Dirk Schadendorf, Jason John Luke, Paolo Antonio Ascierto, Georgina V Long, Piotr Lukasz Rutkowski, Adnan Khattak, Michele Del Vecchio, Luis de la Cruz Merino, Jacek Mackiewicz, Vanna Chiarion Sileni, John M Kirkwood, Caroline Robert, Jean-Jacques Grob, Reinhard Dummer, Matteo S Carlino, Yujie Zhao, Mizuho Kalabis, Clemens Krepler, Alexander Eggermont, Richard A Scolyer
Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma: Outcomes in histopathologic subgroups from the randomized, double-blind, phase 3 KEYNOTE-716 trial. Journal for immunotherapy of cancer 12 (3) (2024)
Jason John Luke, Paolo Antonio Ascierto, Muhammad A Khattak, Luis de la Cruz Merino, Michele Del Vecchio, Piotr Lukasz Rutkowski, Francesco Spagnolo, Jacek Mackiewicz, Vanna Chiarion Sileni, Joanne M Jeter, Caroline Robert, Jean-Jacques Grob, Federica de Galitiis, Dirk Schadendorf, Matteo S Carlino, Xi Lawrence Wu, Mizuho Kalabis, Clemens Krepler, Alexander M M Eggermont, Georgina V Long
Pembrolizumab Versus Placebo as Adjuvant Therapy in Resected Stage IIB or IIC Melanoma: Final Analysis of Distant Metastasis-Free Survival in the Phase III KEYNOTE-716 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (14) (2024)
Nikhil I Khushalani, Patrick A Ott, Matthew J Ferris, Tina Cascone, Dirk Schadendorf, Dung T Le, Manish R Sharma, Fabrice Barlesi, William Sharfman, Jason John Luke, Ignacio Melero Bermejo, Deanne Lathers, Jaclyn Neely, Satyendra Suryawanshi, Abanti Sanyal, James L Holloway, Rasika Suryawanshi, Scott Ely, Neil H Segal
Final results of urelumab, an anti-CD137 agonist monoclonal antibody, in combination with cetuximab or nivolumab in patients with advanced solid tumors. Journal for immunotherapy of cancer 12 (3) (2024)
Esmée P Hoefsmit, Franziska Völlmy, Elisa A Rozeman, Irene L M Reijers, Judith M Versluis, Liesbeth Hoekman, Alexander C J van Akkooi, Georgina V Long, Dirk Schadendorf, Reinhard Dummer, A F Maarten Altelaar, Christian U Blank
Systemic LRG1 Expression in Melanoma is Associated with Disease Progression and Recurrence. Cancer research communications 3 (4) (2023)
Renata Varaljai, Lisa Zimmer, Yahya Al-Matary, Paulien Kaptein, Lea J Albrecht, Batool Shannan, Jan C Brase, Daniel Gusenleitner, Teresa Amaral, Nina Wyss, Jochen Utikal, Lukas Flatz, Florian Rambow, Hans Christian Reinhardt, Jenny Dick, Daniel R Engel, Susanne Horn, Selma Ugurel, Wiebke Sondermann, Elisabeth Livingstone, Antje Sucker, Annette Paschen, Fang Zhao, Jan M Placke, Jasmin M Klose, Wolfgang P Fendler, Daniela S Thommen, Iris Helfrich, Dirk Schadendorf, Alexander Roesch
Author Correction: Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanoma. Nature cancer (2023)
Jan-Malte Placke, D Mertens, A Tasdogan, E Chorti, Dirk Schadendorf, S Ugurel, A Roesch, I Stoffels, J Klode
Multispectral optoacoustic tomography to differentiate between lymph node metastases and coronavirus-19 vaccine-associated lymphadenopathy. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Maximilian Haist, Henner Stege, Friederike Rogall, Yuqi Tan, Imke von Wasielewski, Kai Christian Klespe, Friedegund Meier, Peter Mohr, Katharina C Kähler, Michael Weichenthal, Axel Hauschild, Dirk Schadendorf, Selma Ugurel, Georg Lodde, Lisa Zimmer, Ralf Gutzmer, Dirk Debus, Bastian Schilling, Alexander Kreuter, Jens Ulrich, Frank Meiss, Rudolf Herbst, Andrea Forschner, Ulrike Leiter, Claudia Pfoehler, Martin Kaatz, Fabian Ziller, Jessica C Hassel, Michael Tronnier, Michael Sachse, Edgar Dippel, Patrick Terheyden, Carola Berking, Markus V Heppt, Felix Kiecker, Sebastian Haferkamp, Christoffer Gebhardt, Jan Christoph Simon, Stephan Grabbe, Carmen Loquai
Treatment management for BRAF -mutant melanoma patients with tumor recurrence on adjuvant therapy: a multicenter study from the prospective skin cancer registry ADOREG. Journal for immunotherapy of cancer 11 (9) (2023)
Paolo Antonio Ascierto, Reinhard Dummer, Helen J Gogas, Ana Arance, Mario Mandala, Gabriella Liszkay, Claus Garbe, Dirk Schadendorf, Ivana Krajsova, Ralf Gutzmer, Vanna Chiarion Sileni, Caroline Dutriaux, Jan Willem B de Groot, Naoya Yamazaki, Carmen Loquai, Caroline Robert, Keith T Flaherty
Contribution of MEK Inhibition to BRAF/MEK Inhibitor Combination Treatment of BRAF -Mutant Melanoma: Part 2 of the Randomized, Open-Label, Phase III COLUMBUS Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Carola Berking, Elisabeth Livingstone, Dirk Debus, Carmen Loquai, Michael Weichenthal, Ulrike Leiter, Felix Kiecker, Peter Mohr, Thomas K Eigentler, Janina Remy, Katharina Schober, Markus Vincent Heppt, Imke von Wasielewski, Dirk Schadendorf, Ralf Gutzmer
COMBI-r: A Prospective, Non-Interventional Study of Dabrafenib Plus Trametinib in Unselected Patients with Unresectable or Metastatic BRAF V600-Mutant Melanoma. Cancers 15 (18) (2023)
Esmée P Hoefsmit, Franziska Völlmy, Elisa A Rozeman, Irene L M Reijers, Judith M Versluis, Liesbeth Hoekman, Alexander C J van Akkooi, Georgina V Long, Dirk Schadendorf, Reinhard Dummer, A F Maarten Altelaar, Christian U Blank
Systemic LRG1 Expression in Melanoma is Associated with Disease Progression and Recurrence. Cancer research communications 3 (4) (2023)
Paolo Antonio Ascierto, Evan J Lipson, Reinhard Dummer, James M G Larkin, Georgina V Long, Rachel E Sanborn, Vanna Chiarion Sileni, Brigitte Dreno, Stéphane Dalle, Dirk Schadendorf, Margaret K Callahan, Marta Nyakas, Victoria Atkinson, Carlos Alberto Gomez Roca, Naoya Yamazaki, Hussein A Tawbi, Naomey Sarkis, Deepti M Warad, Sonia Dolfi, Priyam Mitra, Satyendra Suryawanshi, Jean-Jacques Grob
Nivolumab and Relatlimab in Patients With Advanced Melanoma That Had Progressed on Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy: Results From the Phase I/IIa RELATIVITY-020 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Renata Varaljai, Lisa Zimmer, Yahya Al-Matary, Paulien Kaptein, Lea J Albrecht, Batool Shannan, Jan C Brase, Daniel Gusenleitner, Teresa Amaral, Nina Wyss, Jochen Utikal, Lukas Flatz, Florian Rambow, Hans Christian Reinhardt, Jenny Dick, Daniel R Engel, Susanne Horn, Selma Ugurel, Wiebke Sondermann, Elisabeth Livingstone, Antje Sucker, Annette Paschen, Fang Zhao, Jan M Placke, Jasmin M Klose, Wolfgang P Fendler, Daniela S Thommen, Iris Helfrich, Dirk Schadendorf, Alexander Roesch
Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanoma. Nature cancer (2023)
Kaiji Fan, Nalini Srinivas, Linda Kubat, Jan Gravemeyer, Antje Sucker, Dirk Schadendorf, Thilo Gambichler, Jürgen Christian Becker
B-cell lymphoma extra-large (Bcl-xL) is a promising drug target in Merkel cell carcinoma. The British journal of dermatology (2023)
Matthia A Karreman, Alexander T Bauer, Gergely Solecki, Anna Sophie Berghoff, Chanté D Mayer, Katharina Frey, Nils R Hebach, Manuel J Feinauer, Nicole L Schieber, Cedric Tehranian, Luc Mercier, Mahak Singhal, Varun Venkataramani, Marc Cicero Schubert, Daniel Hinze, Michael Hudecek, Iris Helfrich, Dirk Schadendorf, Stefan W Schneider, Dana Westphal, Hellmut G Augustin, Jacky G Goetz, Yannick Schwab, Wolfgang Wick, Frank Winkler
Active remodeling of capillary endothelium via cancer cell-derived MMP9 promotes metastatic brain colonization. Cancer research (2023)
A L Illert, Albrecht Stenzinger, Michael Bitzer, Peter Horak, V I Gaidzik, Y Möller, J Beha, Ö Öner, F Schmitt, S Laßmann, S Ossowski, C P Schaaf, M Hallek, Tim Henrik Brümmendorf, P Albers, T Fehm, P Brossart, H Glimm, Dirk Schadendorf, A Bleckmann, Christian H Brandts, I Esposito, E Mack, C Peters, C Bokemeyer, Stefan Fröhling, T Kindler, Hana Algül, V Heinemann, Hartmut Döhner, Ralf Christian Bargou, V Ellenrieder, P Hillemanns, F Lordick, A Hochhaus, M W Beckmann, T Pukrop, M Trepel, L Sundmacher, S Wesselmann, G Nettekoven, F Kohlhuber, O Heinze, Jan Budczies, M Werner, K Nikolaou, A J Beer, G Tabatabai, W Weichert, U Keilholz, M Boerries, Oliver Kohlbacher, J Duyster, Robert Thimme, T Seufferlein, P Schirmacher, N P Malek
The German Network for Personalized Medicine to enhance patient care and translational research. Nature medicine (2023)
Jan-Malte Placke, Delphine Mertens, Alpaslan Tasdogan, Eleftheria Chorti, Dirk Schadendorf, Selma Ugurel, Alexander Roesch, Ingo Stoffels, Joachim Klode
Multispectral optoacoustic tomography to differentiate between lymph node metastases and coronavirus-19 vaccine-associated lymphadenopathy. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Esmée P Hoefsmit, Franziska Völlmy, Elisa A Rozeman, Irene L M Reijers, Judith M Versluis, Liesbeth Hoekman, Alexander C J van Akkooi, Georgina V Long, Dirk Schadendorf, Reinhard Dummer, A F Maarten Altelaar, Christian U Blank
Systemic LRG1 Expression in Melanoma is Associated with Disease Progression and Recurrence. Cancer research communications 3 (4) (2023)
Esmée P Hoefsmit, Franziska Völlmy, Elisa A Rozeman, Irene L M Reijers, Judith M Versluis, Liesbeth Hoekman, Alexander C J van Akkooi, Georgina V Long, Dirk Schadendorf, Reinhard Dummer, A F Maarten Altelaar, Christian U Blank
Systemic LRG1 Expression in Melanoma is Associated with Disease Progression and Recurrence. Cancer research communications 3 (4) (2023)
Filippo de Braud, Christophe Dooms, Rebecca S Heist, Celeste Lebbè, Martin Wermke, Anas Gazzah, Dirk Schadendorf, Piotr Lukasz Rutkowski, Juergen Wolf, Paolo Antonio Ascierto, Ignacio Gil-Bazo, Shumei Kato, Maria Wolodarski, Meredith A McKean, Eva Muñoz Couselo, Martin Sebastian, Armando Santoro, Vesselina Cooke, Luca Manganelli, Kitty Wan, Anil Gaur, Jaeyeon Kim, Giordano Caponigro, Xuân-Mai Couillebault, Helen Evans, Catarina D Campbell, Sumit Basu, Michele Moschetta, Adil I Daud
Initial Evidence for the Efficacy of Naporafenib in Combination With Trametinib in NRAS -Mutant Melanoma: Results From the Expansion Arm of a Phase Ib, Open-Label Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Laven Mavarani, Sarah Albayrak-Rena, Anja Potthoff, Martin Hower, Sebastian Dolff, Stefanie Sammet, Felix Maischack, Dirk Schadendorf, Börge Schmidt, Stefan Esser, null null
Changes in body mass index, weight, and waist-to-hip ratio over five years in HIV-positive individuals in the HIV Heart Aging Study compared to the general population. Infection (2023)
Claus Garbe, Reinhard Dummer, Teresa Amaral, Rodabe N Amaria, Paolo Antonio Ascierto, Elizabeth M Burton, Brigitte Dreno, Alexander M M Eggermont, Axel Hauschild, Christoph Hoeller, Roland Kaufmann, Celeste Lebbè, Mario Mandala, Alexander M Menzies, David Moreno, Olivier Michielin, Paul Nathan, Sapna Pradyuman Patel, Caroline Robert, Dirk Schadendorf, Paul C Lorigan, Richard A Scolyer, Hussein A Tawbi, Bart A van de Wiel, Christian U Blank, Georgina V Long
Neoadjuvant immunotherapy for melanoma is now ready for clinical practice. Nature medicine (2023)
Simone Stupia, Christina Heeke, Alicia Brüggemann, Anne Zaremba, Beatrice Thier, Julia Kretz, Antje Sucker, Manuel Philip, Gennadiy Zelinskyy, Soldano Ferrone, Alexander Roesch, Susanne Horn, Eva Hadaschik, Dirk Schadendorf, Mirko Trilling, Ulf Dittmer, Klaus Georg Griewank, Fang Zhao, Annette Paschen
HLA class II loss and JAK1/2 deficiency coevolve in melanoma leading to CD4 T cell and IFNγ cross-resistance. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Ines Pires daSilva, Tasnia Ahmed, Jennifer Leigh McQuade, Caroline A Nebhan, John J Park, Judith M Versluis, Patricio Serra-Bellver, Yasir Khan, Tim Slattery, Honey K Oberoi, Selma Ugurel, Lauren E Haydu, Rudolf Herbst, Jochen Utikal, Claudia Pföhler, Patrick Terheyden, Michael Weichenthal, Ralf Gutzmer, Peter Mohr, Rajat Rai, Jessica L Smith, Richard A Scolyer, Ana M Arance, Lisa Pickering, James M G Larkin, Paul C Lorigan, Christian U Blank, Dirk Schadendorf, Michael A Davies, Matteo S Carlino, Douglas B Johnson, Georgina V Long, Serigne N Lô, Alexander M Menzies
Clinical Models to Define Response and Survival With Anti-PD-1 Antibodies Alone or Combined With Ipilimumab in Metastatic Melanoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (10) (2022)
Simone Wendlinger, Jonas Wohlfarth, Sophia Kreft, Claudia Siedel, Teresa Kilian, Ulrich Dischinger, Markus Vincent Heppt, Kilian Wistuba-Hamprecht, Friedegund Meier, Matthias Goebeler, Dirk Schadendorf, Anja Gesierich, Corinna Kosnopfel, Bastian Schilling
Blood Eosinophils Are Associated with Efficacy of Targeted Therapy in Patients with Advanced Melanoma. Cancers 14 (9) (2022)
Volker Arndt, Daniela Doege, Stefan Fröhling, Peter Albers, Hana Algül, Ralf Christian Bargou, Carsten Bokemeyer, Martin Bornhäuser, Christian H Brandts, Peter Brossart, Sara Yvonne Brucker, Tim Henrik Brümmendorf, Hartmut Döhner, Norbert Gattermann, Michael Hallek, Volker Heinemann, Ulrich Keilholz, Thomas Kindler, Cornelia von Levetzow, Florian Lordick, Ulf Peter Neumann, Christoph Peters, Dirk Schadendorf, Stephan Stilgenbauer, Thomas Zander, Daniel Zips, Delia M Braun, Thomas Seufferlein, Gerd Nettekoven, Michael Baumann
Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic. Journal of cancer research and clinical oncology (2022)
Alexander M Menzies, Ines Pires da Silva, Claudia Trojaniello, Elisabeth Vieu, Rodabe N Amaria, Lisa Zimmer, Serigne N Lo, Elizabeth M Burton, Hussein A Tawbi, Dirk Schadendorf, Jean J Grob, Paolo Antonio Ascierto, Georgina V Long
CTLA-4 Blockade Resistance after Relatlimab and Nivolumab. The New England journal of medicine 386 (17) (2022)
Heike Chauvistré, Batool Shannan, Sheena M Daignault-Mill, Robert J Ju, Daniel Picard, Stefanie Egetemaier, Renata Varaljai, Christine S Gibhardt, Antonio Sechi, Farnusch Kaschani, Oliver Keminer, Samantha J Stehbens, Jingjing Liu, Xiangfan Yin, Kirujan Jeyakumar, Felix C E Vogel, Clemens Krepler, Vito W Rebecca, Linda Kubat, Smiths S Lueong, Jan Forster, Susanne Horn, Marc Remke, Michael Ehrmann, Annette Paschen, Jürgen Christian Becker, Iris Helfrich, Daniel Rauh, Markus Kaiser, Sheraz Gul, Meenhard Herylyn, Ivan Bogeski, José Neptuno Rodríguez-López, Nikolas K Haass, Dirk Schadendorf, Alexander Roesch
Persister state-directed transitioning and vulnerability in melanoma. Nature communications 13 (1) (2022)
Andrew W Hahn, Ashley V Menk, Dayana B Rivadeneira, Ryan C Augustin, Mingchu Xu, Jun Li, Xiaogang Wu, Aditya K Mishra, Tuba Nur Gide, Camelia Quek, Yan Zang, Christine N Spencer, Alexander M Menzies, Carrie R Daniel-MacDougall, Courtney W Hudgens, Theodore Scott Nowicki, Lauren E Haydu, Md Abdul Wadud Khan, Vancheswaran Gopalakrishnan, Elizabeth M Burton, Jared C Malke, Julie M Simon, Chantale Bernatchez, Nagireddy Putluri, Scott E Woodman, Vashisht Gopal Y N, Renato A Guerrieri, Grant M Fischer, Jian Wang, Khalida M Wani, John F Thompson, Jeffrey E Lee, Patrick Hwu, Nadim J Ajami, Jeffrey E Gershenwald, Georgina V Long, Richard A Scolyer, Michael T Tetzlaff, Alexander J F Lazar, Dirk Schadendorf, Jennifer A Wargo, Joanne M Jeter, Ralph J DeBerardinis, Han Liang, P Andrew Futreal, Jianhua Zhang, James S Wilmott, Weiyi Peng, Michael A Davies, Greg M Delgoffe, Yana G Najjar, Jennifer Leigh McQuade
Obesity is associated with altered tumor metabolism in metastatic melanoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Claus Garbe, Ulrike Keim, Teresa Amaral, Carola Berking, Thomas K Eigentler, Lukas Flatz, Anja Gesierich, Ulrike Leiter, Rudolf Stadler, Cord Sunderkoetter, Thomas Tüting, Jochen Utikal, Uwe Wollina, Lisa Zimmer, Christos C Zouboulis, Paolo Antonio Ascierto, Alexander M M Eggermont, Jean-Jacques Grob, Axel Hauschild, Lidija Kandolf Sekulovic, Georgina V Long, Jason John Luke, Olivier Michielin, Ketty Peris, Dirk Schadendorf, Joanne M Jeter, Paul C Lorigan, null null
Prognosis of Patients With Primary Melanoma Stage I and II According to American Joint Committee on Cancer Version 8 Validated in Two Independent Cohorts: Implications for Adjuvant Treatment. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (32) (2022)
Elias A T Koch, Anne Petzold, Anja Wessely, Edgar Dippel, Anja Gesierich, Ralf Gutzmer, Jessica C Hassel, Sebastian Haferkamp, Katharina C Kähler, Harald Knorr, Nicole Kreuzberg, Ulrike Leiter, Carmen Loquai, Friedegund Meier, Markus Meissner, Peter Mohr, Claudia Pföhler, Farnaz Rahimi, Dirk Schadendorf, Beatrice Schell, Max Schlaak, Patrick Terheyden, Kai-Martin Thoms, Beatrice Schuler-Thurner, Selma Ugurel, Jens Ulrich, Jochen Sven Utikal, Michael Weichenthal, Fabian Ziller, Carola Berking, Markus Vincent Heppt
Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Re-Induction following Resistance or Toxicity. Cancers 14 (3) (2022)
Hussein A Tawbi, Dirk Schadendorf, Evan J Lipson, Paolo Antonio Ascierto, Luis Matamala, Erika Castillo Gutiérrez, Piotr Rutkowski, Helen J Gogas, Christopher D Lao, Juliana Janoski De Menezes, Stéphane Dalle, Ana Arance, Jean-Jacques Grob, Shivani Srivastava, Mena Abaskharoun, Melissa Hamilton, Sarah Keidel, Katy L Simonsen, Anne Marie Sobiesk, Bin Li, F Stephen Hodi, Georgina V Long, null null
Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma. The New England journal of medicine 386 (1) (2022)
Reinhard Dummer, Keith T Flaherty, Caroline Robert, Ana M Arance, Jan Willem B de Groot, Claus Garbe, Helen J Gogas, Ralf Gutzmer, Ivana Krajsová, Gabriella Liszkay, Carmen Loquai, Mario Mandala, Dirk Schadendorf, Naoya Yamazaki, Alessandra di Pietro, Jean Cantey-Kiser, Michelle Edwards, Paolo Antonio Ascierto
COLUMBUS 5-Year Update: A Randomized, Open-Label, Phase III Trial of Encorafenib Plus Binimetinib Versus Vemurafenib or Encorafenib in Patients With BRAF V600-Mutant Melanoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Philipp Jansen, Adelaida Creosteanu, Viktor Matyas, Amrei Dilling, Ana Pina, Andrea Saggini, Tobias Schimming, Jennifer Landsberg, Birte Burgdorf, Sylvia Giaquinta, Hansgeorg Müller, Michael Emberger, Christian Rose, Lutz Schmitz, Cyrill Geraud, Dirk Schadendorf, Jörg Schaller, Maximilian Alber, Frederick Klauschen, Klaus Georg Griewank
Deep Learning Assisted Diagnosis of Onychomycosis on Whole-Slide Images. Journal of fungi (Basel, Switzerland) 8 (9) (2022)
Reinhard Dummer, Georgina V Long, Caroline Robert, Hussein A Tawbi, Keith T Flaherty, Paolo Antonio Ascierto, Paul D Nathan, Piotr Lukasz Rutkowski, Oleg Leonov, Caroline Dutriaux, Mario Mandala, Paul C Lorigan, Pier Francesco Ferrucci, Jean-Jacques Grob, Nicolas Meyer, Helen J Gogas, Daniil Stroyakovskiy, Ana M Arance, Jan C Brase, Steven Green, Tomas Haas, Aisha Masood, Eduard Gasal, Antoni Ribas, Dirk Schadendorf
Randomized Phase III Trial Evaluating Spartalizumab Plus Dabrafenib and Trametinib for BRAF V600-Mutant Unresectable or Metastatic Melanoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (13) (2022)
Anne Zaremba, Philipp Jansen, Rajmohan Murali, Anand Mayakonda, Anna Riedel, Manuel Philip, Christian Rose, Jörg Schaller, Hansgeorg Müller, Heinz Kutzner, Inga Möller, Nadine Stadtler, Julia Kretz, Antje Sucker, Agnes Bankfalvi, Elisabeth Livingstone, Lisa Zimmer, Susanne Horn, Annette Paschen, Christoph Plass, Dirk Schadendorf, Eva Hadaschik, Pavlo Lutsik, Klaus Georg Griewank
Genetic and methylation profiles distinguish benign, malignant and spitzoid melanocytic tumors. International journal of cancer 151 (9) (2022)
Jeffrey S Weber, Dirk Schadendorf, Michele Del Vecchio, James M G Larkin, Victoria Atkinson, Michael Schenker, Jacopo Pigozzo, Helen J Gogas, Stéphane Dalle, Nicolas Meyer, Paolo Antonio Ascierto, Shahneen Sandhu, Thomas Eigentler, Ralf Gutzmer, Jessica C Hassel, Caroline Robert, Matteo S Carlino, Anna Maria Di Giacomo, Marcus O Butler, Eva Muñoz Couselo, Michael P Brown, Piotr Lukasz Rutkowski, Andrew M Haydon, Jean-Jacques Grob, Jacob Schachter, Paola Queirolo, Luis de la Cruz Merino, Andre van der Westhuizen, Alexander M Menzies, Sandra Re, Tuba Bas, Veerle de Pril, Julia Braverman, Daniel J Tenney, Hao Tang, Georgina V Long
Adjuvant Therapy of Nivolumab Combined With Ipilimumab Versus Nivolumab Alone in Patients With Resected Stage IIIB-D or Stage IV Melanoma (CheckMate 915). Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Neil D Gross, David Michael Miller, Nikhil I Khushalani, Vasu Divi, Emily S Ruiz, Evan J Lipson, Friedegund Meier, Yungpo B Su, Paul L Swiecicki, Jennifer Atlas, Jessica L Geiger, Axel Hauschild, Jennifer H Choe, Brett G M Hughes, Dirk Schadendorf, Vishal A Patel, Jade Homsi, Janis M Taube, Annette M Lim, Renata Ferrarotto, Howard L Kaufman, Frank Seebach, Israel Lowy, Suk-Young Yoo, Melissa Mathias, Keilah Fenech, Hyunsil Han, Matthew G Fury, Danny Rischin
Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma. The New England journal of medicine 387 (17) (2022)
Dirk Schadendorf, Reinhard Dummer, Caroline Robert, Antoni Ribas, Ryan J Sullivan, Timothy Panella, Meredith A McKean, Edgardo S Santos, Kimberli Brill, Anna Polli, Alessandra di Pietro, Paolo Antonio Ascierto
STARBOARD: encorafenib + binimetinib + pembrolizumab for first-line metastatic/unresectable BRAF V600-mutant melanoma. Future oncology (London, England) 18 (17) (2022)
Philipp Jansen, Georg Lodde, K G Griewank, E Hadaschik, Alexander Roesch, S Ugurel, L Zimmer, E Livingstone, Dirk Schadendorf
Management of partial and non-responding cutaneous squamous cell carcinoma. Journal of the European Academy of Dermatology and Venereology : JEADV (2021)
Tan-Trieu Nguyen, LeeAnn Ramsay, Mozhdeh Ahanfeshar-Adams, Mathieu Lajoie, Dirk Schadendorf, Tommy Alain, Ian R Watson
Mutations in the IFNγ-JAK-STAT Pathway Causing Resistance to Immune Checkpoint Inhibitors in Melanoma Increase Sensitivity to Oncolytic Virus Treatment. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (12) (2021)
R Gutzmer, H-J Schulze, Axel Hauschild, Ulrike Leiter, Friedegund Meier, S Haferkamp, C Ulrich, R U Wahl, Carola Berking, R Herbst, M Häckl, Dirk Schadendorf
Effectiveness, safety and utilization of vismodegib in locally advanced basal cell carcinoma under real-world conditions in Germany - The non-interventional study NIELS. Journal of the European Academy of Dermatology and Venereology : JEADV 35 (8) (2021)
Alexander M M Eggermont, Christian U Blank, Mario Mandala, Georgina V Long, Victoria G Atkinson, Stéphane Dalle, Andrew M Haydon, Andrey Meshcheryakov, Adnan Khattak, Matteo S Carlino, Shahneen Sandhu, James M G Larkin, Susana Puig Sardà, Paolo Antonio Ascierto, Piotr Rutkowski, Dirk Schadendorf, Rutger Koornstra, Leonel Hernandez-Aya, Anna Maria Di Giacomo, Alfonsus J M van den Eertwegh, Jean-Jacques Grob, Ralf Gutzmer, Rahima Jamal, Paul C Lorigan, Alexander C J van Akkooi, Clemens Krepler, Nageatte Ibrahim, Sandrine Marreaud, Michal Kicinski, Stefan Suciu, Caroline Robert
Reply to E. Hindié. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (8) (2021)
Jan C Brase, Robert F H Walter, Alexander Savchenko, Daniel Gusenleitner, James Garrett, Tobias Schimming, Renata Varaljai, Deborah Castelletti, Ju Kim, Naveen Dakappagari, Ken Schultz, Caroline Robert, Georgina V Long, Paul D Nathan, Antoni Ribas, Keith T Flaherty, Boguslawa Karaszewska, Jacob Schachter, Antje Sucker, Kurt W Schmid, Lisa Zimmer, Elisabeth Livingstone, Eduard Gasal, Dirk Schadendorf, Alexander Roesch
Role of Tumor-Infiltrating B Cells in Clinical Outcome of Patients with Melanoma Treated With Dabrafenib Plus Trametinib. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (16) (2021)
Hai Hu, Alireza Khodadadi-Jamayran, Igor Dolgalev, Hyunwoo Cho, Sana Badri, Luis A Chiriboga, Briana Zeck, Miguel Lopez de Rodas, Catríona M Dowling, Kristen Labbe, Jiehui Deng, Ting Chen, Hua Zhang, Paul Zappile, Ze Chen, Beatrix Ueberheide, Angeliki Karatza, Han Han, Michela Ranieri, Sittinon Tang, George Jour, Iman Osman, Antje Sucker, Dirk Schadendorf, Aristotelis Tsirigos, Kurt A Schalper, Vamsidhar Velcheti, Hsin-Yi Huang, Yujuan Jin, Hongbin Ji, John T Poirier, Fei Li, Kwok-Kin Wong
Targeting the Atf7ip-Setdb1 Complex Augments Antitumor Immunity by Boosting Tumor Immunogenicity. Cancer immunology research 9 (11) (2021)
Aljosja Rogiers, Ines Pires da Silva, Chiara Tentori, Carlo Alberto Tondini, Joseph M Grimes, Megan H Trager, Sharon H Nahm, Leyre Zubiri, Michael Manos, Peter Bowling, Arielle Elkrief, Neha Papneja, Maria Grazia Vitale, April A N Rose, Jessica S W Borgers, Severine Roy, Joanna Mangana, Thiago Pimentel Muniz, Tim Cooksley, Jeremy Lupu, Alon Vaisman, Samuel D Saibil, Marcus O Butler, Alexander M Menzies, Matteo S Carlino, Michael Erdmann, Carola Berking, Lisa Zimmer, Dirk Schadendorf, Laura Pala, Paola Queirolo, Christian Posch, Axel Hauschild, Reinhard Dummer, John Haanen, Christian U Blank, Caroline Robert, Ryan J Sullivan, Paolo Antonio Ascierto, Wilson H Miller, F Stephen Hodi, Karijn P M Suijkerbuijk, Kerry L Reynolds, Osama E Rahma, Paul C Lorigan, Richard D Carvajal, Serigne N Lô, Mario Mandala, Georgina V Long
Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition. Journal for immunotherapy of cancer 9 (1) (2021)
Jedd D Wolchok, Vanna Chiarion Sileni, Rene Gonzalez, Jean-Jacques Grob, Piotr Lukasz Rutkowski, Christopher D Lao, C Lance Cowey, Dirk Schadendorf, John Wagstaff, Reinhard Dummer, Pier Francesco Ferrucci, Michael Smylie, Marcus O Butler, Andrew Hill, Ivan Marquez-Rodas, John B A G Haanen, Massimo Guidoboni, Michele Maio, Patrick Schöffski, Matteo S Carlino, Celeste Lebbè, Grant A McArthur, Paolo Antonio Ascierto, Gregory A Daniels, Georgina V Long, Tuba Bas, Corey Ritchings, James M G Larkin, Frank Stephen Hodi
Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)
F Stephen Hodi, Jedd D Wolchok, Dirk Schadendorf, James Larkin, Georgina V Long, Xiaozhong Qian, Abdel Saci, Tina C Young, Sujaya Srinivasan, Han Chang, Hao Tang, Megan Wind-Rotolo, Jasmine I Rizzo, Donald G Jackson, Paolo Antonio Ascierto
TMB and Inflammatory Gene Expression Associated with Clinical Outcomes following Immunotherapy in Advanced Melanoma. Cancer immunology research 9 (10) (2021)
Chris J Frangieh, Johannes C Melms, Pratiksha I Thakore, Kathryn R Geiger-Schuller, Patricia Ho, Adrienne M Luoma, Brian Cleary, Livnat Jerby, Shruti Malu, Michael S Cuoco, Maryann Zhao, Casey R Ager, Meri Rogava, Lila Hovey, Asaf Rotem, Chantale Bernatchez, Kai W Wucherpfennig, Bruce E Johnson, Orit Rozenblatt-Rosen, Dirk Schadendorf, Aviv Regev, Benjamin Izar
Multimodal pooled Perturb-CITE-seq screens in patient models define mechanisms of cancer immune evasion. Nature genetics 53 (3) (2021)
Philipp Jansen, Georg Lodde, A Wetter, A Welt, M Stuschke, U Dührsen, I Stoffels, J Klode, E Livingstone, L Zimmer, Alexander Roesch, E Hadaschik, K G Griewank, Dirk Schadendorf, S Ugurel
Checkpoint immunotherapy of cutaneous squamous cell carcinoma in patients suffering from chronic lymphocytic leukaemia: divergent outcomes in two men treated with PD-1 inhibitors. Journal of the European Academy of Dermatology and Venereology : JEADV (2021)
Lars Michel, Iris Helfrich, Ulrike Barbara Hendgen-Cotta, Raluca-Ileana Mincu, Sebastian Korste, Simone Maria Mrotzek, Armin Spomer, Andrea Odersky, Christoph Rischpler, Ken Herrmann, Lale Umutlu, Cristina Coman, Robert Ahrends, Albert Sickmann, Stefanie Löffek, Elisabeth Livingstone, Selma Ugurel, Lisa Zimmer, Matthias Gunzer, Dirk Schadendorf, Matthias Totzeck, Tienush Rassaf
Targeting early stages of cardiotoxicity from anti-PD1 immune checkpoint inhibitor therapy. European heart journal (2021)
Georg Lodde, Andrea Forschner, Jessica Hassel, Lena M Wulfken, Friedegund Meier, Peter Mohr, Katharina Kähler, Bastian Schilling, Carmen Loquai, Carola Berking, Svea Hüning, Kerstin Schatton, Christoffer Gebhardt, Julia Eckardt, Ralf Gutzmer, Lydia Reinhardt, Valerie Glutsch, Ulrike Nikfarjam, Michael Erdmann, Andreas Stang, Bernd Kowall, Alexander Roesch, Selma Ugurel, Lisa Zimmer, Dirk Schadendorf, Elisabeth Livingstone
Factors Influencing the Adjuvant Therapy Decision: Results of a Real-World Multicenter Data Analysis of 904 Melanoma Patients. Cancers 13 (10) (2021)
Julia Höhn, Achim Hekler, Eva Krieghoff-Henning, Jakob Nikolas Kather, Jochen Sven Utikal, Friedegund Meier, Frank Friedrich Gellrich, Axel Hauschild, Lars Einar French, Justin Gabriel Schlager, Kamran Ghoreschi, Tabea Wilhelm, Heinz Kutzner, Markus Vincent Heppt, Sebastian Haferkamp, Wiebke Sondermann, Dirk Schadendorf, Bastian Schilling, Roman Christoph Maron, Max Schmitt, Tanja Jutzi, Stefan Fröhling, Daniel B Lipka, Titus Josef Brinker
Integrating Patient Data Into Skin Cancer Classification Using Convolutional Neural Networks: Systematic Review. Journal of medical Internet research 23 (7) (2021)
David de Semir, Vladimir Bezrookove, Mehdi Nosrati, Altaf A Dar, James R Miller, Stanley P Leong, Kevin B Kim, Wilson Liao, Liliana Soroceanu, Sean McAllister, Robert J Debs, Dirk Schadendorf, Sancy A Leachman, James E Cleaver, Mohammed Kashani-Sabet
Nuclear Receptor Coactivator NCOA3 Regulates UV Radiation-Induced DNA Damage and Melanoma Susceptibility. Cancer research 81 (11) (2021)
Anastasia Gangaev, Elisa A Rozeman, Maartje W Rohaan, Olga I Isaeva, Daisy Philips, Sanne Patiwael, Joost H van den Berg, Antoni Ribas, Dirk Schadendorf, Bastian Schilling, Ton N M Schumacher, Christian U Blank, John B A G Haanen, Pia Kvistborg
Differential effects of PD-1 and CTLA-4 blockade on the melanoma-reactive CD8 T cell response. Proceedings of the National Academy of Sciences of the United States of America 118 (43) (2021)
Reinhard Dummer, Axel Hauschild, Mario Santinami, Victoria Atkinson, Mario Mandalà, John M Kirkwood, Vanna Chiarion Sileni, James Larkin, Marta Nyakas, Caroline Dutriaux, Andrew Haydon, Caroline Robert, Laurent Mortier, Jacob Schachter, Thierry Lesimple, Ruth Plummer, Kohinoor Dasgupta, Eduard Gasal, Monique Tan, Georgina V Long, Dirk Schadendorf
Five-Year Analysis of Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma. The New England journal of medicine 383 (12) (2020)
Renata Varaljai, S Elouali, S S Lueong, K Wistuba-Hamprecht, T Seremet, J T Siveke, J C Becker, A Sucker, A Paschen, P A Horn, B Neyns, B Weide, Dirk Schadendorf, Alexander Roesch
The predictive and prognostic significance of cell-free DNA concentration in melanoma. Journal of the European Academy of Dermatology and Venereology : JEADV 35 (2) (2020)
Alexander M M Eggermont, Christian U Blank, Mario Mandala, Georgina V Long, Victoria G Atkinson, Stéphane Dalle, Andrew M Haydon, Andrey Meshcheryakov, Adnan Khattak, Matteo S Carlino, Shahneen Sandhu, James M G Larkin, Susana Puig, Paolo Antonio Ascierto, Piotr Rutkowski, Dirk Schadendorf, Rutger Koornstra, Leonel Hernandez-Aya, Anna Maria Di Giacomo, Alfonsus J M van den Eertwegh, Jean-Jacques Grob, Ralf Gutzmer, Rahima Jamal, Paul C Lorigan, Alexander C J van Akkooi, Clemens Krepler, Nageatte Ibrahim, Sandrine Marreaud, Michal Kicinski, Stefan Suciu, Caroline Robert
Longer Follow-Up Confirms Recurrence-Free Survival Benefit of Adjuvant Pembrolizumab in High-Risk Stage III Melanoma: Updated Results From the EORTC 1325-MG/KEYNOTE-054 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 38 (33) (2020)
Caroline Robert, Georgina V Long, Benjamin Brady, Caroline Dutriaux, Anna Maria Di Giacomo, Laurent Mortier, Piotr Rutkowski, Jessica C Hassel, Catriona M McNeil, Ewa Anna Kalinka, Celeste Lebbè, Julie Charles, Micaela M Hernberg, Kerry Joane Savage, Vanna Chiarion Sileni, Catalin Mihalcioiu, Cornelia Mauch, Ana Arance, Francesco Cognetti, Lars Ny, Henrik Schmidt, Dirk Schadendorf, Helen J Gogas, Jesús Zoco, Sandra Re, Paolo Antonio Ascierto, Victoria Atkinson
Five-Year Outcomes With Nivolumab in Patients With Wild-Type BRAF Advanced Melanoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 38 (33) (2020)
Ellen Brenner, Barbara F Schörg, Fatima Ahmetlić, Thomas Wieder, Franz Joachim Hilke, Nadine Simon, Christopher Schroeder, German Demidov, Tanja Riedel, Birgit Fehrenbacher, Martin Schaller, Andrea Forschner, Thomas Eigentler, Heike Niessner, Tobias Sinnberg, Katharina S Böhm, Nadine Hömberg, Heidi Braumüller, Daniel Dauch, Stefan Zwirner, Lars Zender, Dominik Sonanini, Albert Geishauser, Jürgen Bauer, Martin Eichner, Katja J Ottmüller, Andreas Beilhack, Saskia Biskup, Dennis Döcker, Dirk Schadendorf, Leticia Quintanilla-Martinez, Bernd J Pichler, Manfred Kneilling, Ralph Mocikat, Martin Röcken
Cancer immune control needs senescence induction by interferon-dependent cell cycle regulator pathways in tumours. Nature communications 11 (1) (2020)
Maria Teresa Landi, D Timothy Timothy Bishop, Stuart Macgregor, Mitchell J Machiela, Alexander J Stratigos, Paola Ghiorzo, Myriam Brossard, Donato Calista, Jiyeon Choi, Maria Concetta Fargnoli, Tongwu Zhang, Monica Rodolfo, Adam J Trower, Chiara Menin, Jacobo Martinez, Andreas Hadjisavvas, Lei Song, Irene Stefanaki, Richard A Scolyer, Rose Yang, Alisa M Goldstein, Miriam Potrony, Katerina P Kypreou, Lorenza Pastorino, Paola Queirolo, Cristina Pellegrini, Laura Cattaneo, Matthew Zawistowski, Pol Gimenez-Xavier, Arantxa Rodriguez, Lisa Elefanti, Siranoush Manoukian, Licia Rivoltini, Blair Hamilton Smith, Maria A Loizidou, Laura Del Regno, Daniela Massi, Mario Mandala, Kiarash Khosrotehrani, Lars A Akslen, Christopher Ian Amos, Per A Andresen, Marie-Françoise Avril, Esther Azizi, Hans Peter Soyer, Veronique Bataille, Bruna Dalmasso, Lisa M Bowdler, Kathryn P Burdon, Wei V Chen, Veryan Codd, Jamie E Craig, Tadeusz Dębniak, Mario Falchi, Shenying Fang, Eitan Friedman, Sarah Simi, Pilar Galan, Zaida Garcia-Casado, Elizabeth M Gillanders, Scott D Gordon, Adele Green, Nelleke A Gruis, Johan Hansson, Mark Harland, Jessica Harris, Per Helsing, Anjali Henders, Marko Hočevar, Veronica Höiom, David Hunter, Christian Ingvar, Rajiv Kumar, Julie Lang, G Mark Lathrop, Jeffrey E Lee, Xin Li, Jan Lubiński, Rona M Mackie, Maryrose Malt, Josep Malvehy, Kerrie McAloney, Hamida Mohamdi, Anders Molven, Eric K Moses, Rachel E Neale, Srdjan Novaković, Dale R Nyholt, Håkan Olsson, Nicholas Orr, Lars G Fritsche, Joan Anton Puig-Butille, Abrar A Qureshi, Graham L Radford-Smith, Juliette Randerson-Moor, Celia Requena, Casey Rowe, Nilesh J Samani, Marianna Sanna, Dirk Schadendorf, Hans-Joachim Schulze, Lisa A Simms, Bernard Mark Smithers, Fengju Song, Anthony J Swerdlow, Nienke van der Stoep, Nicole A Kukutsch, Alessia Visconti, Leanne Wallace, Sarah V Ward, Lawrie Wheeler, Richard A Sturm, Amy Hutchinson, Kristine Jones, Michael Malasky, Aurelie Vogt, Weiyin Zhou, Karen A Pooley, David E Elder, Jiali Han, Belynda D Hicks, Nicholas K Hayward, Peter A Kanetsky, Chad Brummett, Grant W Montgomery, Catherine M Olsen, Caroline Hayward, Alison M Dunning, Nicholas G Martin, Evangelos Evangelou, Graham J Mann, Georgina Long, Paul David Peter Pharoah, Douglas F Easton, Jennifer H Barrett, Anne E Cust, Goncalo Abecasis, David L Duffy, David C Whiteman, Helen Gogas, Arcangela De Nicolo, Margaret A Tucker, Julia A Newton-Bishop, null null, null null, null null, null null, null null, null null, null null, null null, null null, Ketty Peris, Stephen J Chanock, Florence Demenais, Kevin M Brown, Susana Puig, Eduardo Nagore, Jianxin Shi, Mark M Iles, Matthew H Law
Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility. Nature genetics 52 (5) (2020)
Kaiji Fan, Ivelina Spassova, Jan Gravemeyer, Cathrin Ritter, Kai Horny, Anja Lange, Thilo Gambichler, Niels Ødum, David Schrama, Dirk Schadendorf, Selma Ugurel, Jürgen Christian Becker
Merkel cell carcinoma-derived exosome-shuttle miR-375 induces fibroblast polarization by inhibition of RBPJ and p53. Oncogene 40 (5) (2020)
F Koch, K A Salva, M Wirtz, E Hadaschik, Renata Varaljai, Dirk Schadendorf, Alexander Roesch
Efficacy of cold atmospheric plasma vs. diclofenac 3% gel in patients with actinic keratoses: a prospective, randomized and rater-blinded study (ACTICAP). Journal of the European Academy of Dermatology and Venereology : JEADV 34 (12) (2020)
Paul David, Malgorzata Drabczyk-Pluta, Eva Pastille, Torben Knuschke, Tanja Werner, Nadine Honke, Dominik A Megger, Ilseyar Akhmetzyanova, Namir Shaabani, Annette Eyking-Singer, Elke Cario, Olivia Kershaw, Achim D Gruber, Matthias Tenbusch, Kirsten K Dietze, Mirko Trilling, Jia Liu, Dirk Schadendorf, Hendrik Streeck, Karl S Lang, Youhua Xie, Lisa Zimmer, Barbara Sitek, Annette Paschen, Astrid M Westendorf, Ulf Dittmer, Gennadiy Zelinskyy
Combination immunotherapy with anti-PD-L1 antibody and depletion of regulatory T cells during acute viral infections results in improved virus control but lethal immunopathology. PLoS pathogens 16 (3) (2020)
Reinhard Dummer, Celeste Lebbé, Victoria Atkinson, Mario Mandalà, Paul D Nathan, Ana Arance, Erika Richtig, Naoya Yamazaki, Caroline Robert, Dirk Schadendorf, Hussein A Tawbi, Paolo Antonio Ascierto, Antoni Ribas, Keith T Flaherty, Neha Pakhle, Catarina D Campbell, Daniel Gusenleitner, Aisha Masood, Jan C Brase, Eduard Gasal, Georgina V Long
Combined PD-1, BRAF and MEK inhibition in advanced BRAF-mutant melanoma: safety run-in and biomarker cohorts of COMBI-i. Nature medicine 26 (10) (2020)
Dirk Schadendorf, A Hauschild, S Fosko, D Zloty, B Labeille, J-J Grob, S Puig, M Makrutzki, F Gilberg, A Hong, Brigitte Dreno, G Rogers, R Kunstfeld
Quality-of-life analysis with intermittent vismodegib regimens in patients with multiple basal cell carcinomas: patient-reported outcomes from the MIKIE study. Journal of the European Academy of Dermatology and Venereology : JEADV 34 (9) (2020)
Jake R Conway, Felix Dietlein, Amaro Taylor-Weiner, Saud AlDubayan, Natalie I Vokes, Tanya Keenan, Brendan Reardon, Meng Xiao He, Claire A Margolis, Jason L Weirather, Rizwan Haq, Bastian Schilling, F Stephen Hodi, Dirk Schadendorf, David Liu, Eliezer Van Allen
Integrated molecular drivers coordinate biological and clinical states in melanoma. Nature genetics 52 (12) (2020)
Taisuke Matsuya, Yasuhiro Nakamura, Shigeto Matsushita, Ryota Tanaka, Yukiko Teramoto, Yuri Asami, Jiro Uehara, Megumi Aoki, Kentaro Yamamura, Yoshiyuki Nakamura, Yasuhiro Fujisawa, Elisabeth Livingstone, Lisa Zimmer, Dirk Schadendorf, Hiroshi Kagamu, Manabu Fujimoto, Masaru Honma, Akemi Ishida-Yamamoto, Ryuichiro Araki, Akifumi Yamamoto
Vitiligo expansion and extent correlate with durable response in anti-programmed death 1 antibody treatment for advanced melanoma: A multi-institutional retrospective study. The Journal of dermatology 47 (6) (2020)
Ivelina Spassova, Selma Ugurel, Patrick Terheyden, Antje Sucker, Jessica C Hassel, Cathrin Ritter, Linda Kubat, Daniel Habermann, Farnoush Farahpour, Mohammadkarim Saeedghalati, Lukas Peiffer, Rajiv Kumar, David Schrama, Daniel Hoffmann, Dirk Schadendorf, Jürgen Christian Becker
Predominance of Central Memory T Cells with High T-Cell Receptor Repertoire Diversity is Associated with Response to PD-1/PD-L1 Inhibition in Merkel Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (9) (2020)
Michael F Emmons, Fernanda Faião-Flores, Ritin Sharma, Ram Thapa, Jane L Messina, Jürgen Christian Becker, Dirk Schadendorf, Edward Seto, Vernon K Sondak, John M Koomen, Yian A Chen, Eric K Lau, Lixin Wan, Jonathan D Licht, Keiran S M Smalley
HDAC8 Regulates a Stress Response Pathway in Melanoma to Mediate Escape from BRAF Inhibitor Therapy. Cancer research 79 (11) (2019)
Nicolas Jacquelot, Takahiro Yamazaki, Maria Paula Roberti, Connie P M Duong, Miles C Andrews, Loic Verlingue, Gladys Ferrere, Sonia Becharef, Marie Vétizou, Romain Daillère, Meriem Messaoudene, David P Enot, Gautier Stoll, Stefano Ugel, Ilaria Marigo, Shin Foong Ngiow, Aurélien Marabelle, Armelle Prévost-Blondel, Pierre-Olivier Gaudreau, Vancheswaran Gopalakrishnan, Alexander M Eggermont, Paule Opolon, Christophe Klein, Gabriele Madonna, Paolo Antonio Ascierto, Antje Sucker, Dirk Schadendorf, Mark J Smyth, Jean-Charles Soria, Guido Kroemer, Vincenzo Bronte, Jennifer A Wargo, Laurence Zitvogel
Sustained Type I interferon signaling as a mechanism of resistance to PD-1 blockade. Cell research 29 (10) (2019)
Johannes C Melms, Sreeram Vallabhaneni, Caitlin E Mills, Clarence Yapp, Jia-Yun Chen, Eugenio Morelli, Patricia Waszyk, Sushil Kumar, Derrick Deming, Nienke Moret, Steven Rodriguez, Kartik Subramanian, Meri Rogava, Adam N R Cartwright, Adrienne Luoma, Shaolin Mei, Titus Josef Brinker, David M Miller, Alexander Spektor, Dirk Schadendorf, Nicolo Riggi, Kai W Wucherpfennig, Peter Karl Sorger, Benjamin Izar
Inhibition of Haspin Kinase Promotes Cell-Intrinsic and Extrinsic Antitumor Activity. Cancer research 80 (4) (2019)
David Liu, Bastian Schilling, Derek Liu, Antje Sucker, Elisabeth Livingstone, Livnat Jerby-Arnon, Lisa Zimmer, Ralf Gutzmer, Imke Satzger, Carmen Loquai, Stephan Grabbe, Natalie Vokes, Claire A Margolis, Jake Conway, Meng Xiao He, Haitham Elmarakeby, Felix Dietlein, Diana Miao, Adam Tracy, Helen Gogas, Simone M Goldinger, Jochen Sven Utikal, Christian U Blank, Ricarda Rauschenberg, Dagmar von Bubnoff, Angela Krackhardt, Benjamin Weide, Sebastian Haferkamp, Felix Kiecker, Ben Izar, Levi Garraway, Aviv Regev, Keith T Flaherty, Annette Paschen, Eliezer Van Allen, Dirk Schadendorf
Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma. Nature medicine 25 (12) (2019)
Titus Josef Brinker, Christian Martin Brieske, Stefan Esser, Joachim Klode, Ute Mons, Anil Batra, Tobias Rüther, Horst-Walter Birk, Alexander H Enk, Christof von Kalle, Carola Berking, Markus Vincent Heppt, Martina V Gatzka, Breno Bernardes-Souza, Richard F Schlenk, Dirk Schadendorf
A Face-Aging App for Smoking Cessation in a Waiting Room Setting: Pilot Study in an HIV Outpatient Clinic. Journal of medical Internet research 20 (8) (2018)
Titus Josef Brinker, Achim Hekler, Christof von Kalle, Dirk Schadendorf, Stefan Esser, Carola Berking, Martina T Zacher, Wiebke Sondermann, Niels Grabe, Theresa Steeb, Jochen Sven Utikal, Lars Einar French, Alexander H Enk
Teledermatology: Comparison of Store-and-Forward Versus Live Interactive Video Conferencing. Journal of medical Internet research 20 (10) (2018)
Titus Josef Brinker, Marlene Heckl, Martina V Gatzka, Markus Vincent Heppt, Henrique Resende Rodrigues, Sven Schneider, Wiebke Sondermann, Carolina de Almeida E Silva, Michael Constantin Kirchberger, Joachim Klode, Alexander H Enk, Sarah Knispel, Christof von Kalle, Ingo Stoffels, Dirk Schadendorf, Yasuhiro Nakamura, Stefan Esser, Aisllan Assis, Breno Bernardes-Souza
A Skin Cancer Prevention Facial-Aging Mobile App for Secondary Schools in Brazil: Appearance-Focused Interventional Study. JMIR mHealth and uHealth 6 (3) (2018)
Titus Josef Brinker, Achim Hekler, Jochen Sven Utikal, Niels Grabe, Dirk Schadendorf, Joachim Klode, Carola Berking, Theresa Steeb, Alexander H Enk, Christof von Kalle
Skin Cancer Classification Using Convolutional Neural Networks: Systematic Review. Journal of medical Internet research 20 (10) (2018)
Titus Josef Brinker, Andreas Dawid Owczarek, Horst-Walter Birk, David Alexander Groneberg, Christian Martin Brieske, Philipp Jansen, Joachim Klode, Ingo Stoffels, Dirk Schadendorf, Benjamin Izar, Fabian Norbert Fries, Felix Johannes Hofmann
A Medical Student-Delivered Smoking Prevention Program, Education Against Tobacco, for Secondary Schools in Germany: Randomized Controlled Trial. Journal of medical Internet research 19 (6) (2017)
Titus Josef Brinker, Dirk Schadendorf, Joachim Klode, Ioana Cosgarea, Alexander Rösch, Philipp Jansen, Ingo Stoffels, Benjamin Izar
Photoaging Mobile Apps as a Novel Opportunity for Melanoma Prevention: Pilot Study. JMIR mHealth and uHealth 5 (7) (2017)

Dirk Schadendorf.css-eqlu8i{font-size:small;padding-left:4px;} (D Schadendorf)

Publication Activity (10 Years)

Top Topics

Top Venues

Dirk Schadendorf (D Schadendorf)